<DOC>
	<DOCNO>NCT00107874</DOCNO>
	<brief_summary>Postpartum hemorrhage ( PPH ) rank among lead cause maternal morbidity mortality , develop develop country . With trial , seek determine effectiveness oral misoprostol uterotonic drug comparison intravenous oxytocin , patient low risk PPH undergo non-scheduled Cesarean section . We therefore compare intra- postoperative blood loss , well drug relate side effect patient , treat surgical anesthesiological team one institution .</brief_summary>
	<brief_title>Oral Misoprostol Versus Intravenous Oxytocin Preventing Blood Loss After Non-Scheduled Cesarean Section</brief_title>
	<detailed_description>Postpartum hemorrhage ( PPH ) still among leading cause maternal morbidity mortality . The incidence PPH reduce active management third stage labor include use uterotonics pharmacological prophylaxis . However , on-going debate optimal drug selection since uterotonics oxytocin methylergometrine liable specific side effect complication administer within dose range need effective PPH . In search alternative conventional standard uterotonics , misoprostol ( prostaglandin E1 ) turn effective therapeutic option implement actual treatment regimen . The objective study compare effectiveness oral applicated misoprostol versus intravenous oxytocin reduce blood loss low risk obstetric patient undergo non-scheduled cesarean section ( CS ) spinal anesthesia . Comparison : In prospective , double blind study , parturients undergo CS randomize receive either ) oral misoprostol infusion normal saline supplement placebo , b ) oral placebo infusion normal saline , supplement oxytocin subsequently intravenous oxytocin cord clamp group . The primary outcome amount intra- postoperative blood loss occurrence drug-related side effect .</detailed_description>
	<mesh_term>Hemorrhage</mesh_term>
	<mesh_term>Postpartum Hemorrhage</mesh_term>
	<mesh_term>Misoprostol</mesh_term>
	<mesh_term>Oxytocin</mesh_term>
	<criteria>Nonscheduled primary secondary Cesarean section ( CS ) 37th week gestation Emergency CS Fetal distress Fetal malformation Preeclampsia HELLP ( HemolysisElevated Liver enzymesLow Platelet count syndrome ) Hypersensitivity prostaglandins Coagulopathy Severe systemic disorder An American Society Anesthesiologists ( ASA ) physical status &gt; /= 3 Severe asthma Prior myomectomy Maternal fever ( &gt; 38.5 Â°C )</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
	<keyword>Maternal</keyword>
	<keyword>morbidity</keyword>
	<keyword>mortality</keyword>
	<keyword>pregnancy</keyword>
	<keyword>postpartum hemorrhage</keyword>
	<keyword>Cesarean Section</keyword>
</DOC>